Longeveron

LGVNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$8.289 M

$2.60 -4.41%

Close of 23 Sept 2026

Revenue

$1.20M

#3470 by revenue

Earnings

-$22.7M

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →

#439FibroBiologicsFBLG$8.86M
#440SoligenixSNGX$8.38M
#441LongeveronLGVN$8.29M
#442ImunonIMNN$8.25M
#443ExicureXCUR$8.12M

What if Longeveron were worth as much as…

Open the what-if tool →

Gold $29.8T

$9,361,689

Per share 3,600,650× higher

Bitcoin $1.69T

$531,372.25

Per share 204,374× higher

Nvidia $5.43T

$1,704,659

Per share 655,638× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for Longeveron are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 24 Sept 2026. Read the methodology.